Published online Feb 28, 2016. doi: 10.4254/wjh.v8.i6.307
Peer-review started: August 21, 2015
First decision: October 13, 2015
Revised: January 11, 2016
Accepted: January 27, 2016
Article in press: January 29, 2016
Published online: February 28, 2016
Processing time: 188 Days and 12.2 Hours
Bacterial infection is common and accounts for major morbidity and mortality in cirrhosis. Patients with cirrhosis are immunocompromised and increased susceptibility to develop spontaneous bacterial infections, hospital-acquired infections, and a variety of infections from uncommon pathogens. Once infection develops, the excessive response of pro-inflammatory cytokines on a pre-existing hemodynamic dysfunction in cirrhosis further predispose the development of serious complications such as shock, acute-on-chronic liver failure, renal failure, and death. Spontaneous bacterial peritonitis and bacteremia are common in patients with advanced cirrhosis, and are important prognostic landmarks in the natural history of cirrhosis. Notably, the incidence of infections from resistant bacteria has increased significantly in healthcare-associated settings. Serum biomarkers such as procalcitonin may help to improve the diagnosis of bacterial infection. Preventive measures (e.g., avoidance, antibiotic prophylaxis, and vaccination), early recognition, and proper management are required in order to minimize morbidity and mortality of infections in cirrhosis.
Core tip: Bacterial infection is common and accounts for major morbidity and mortality in cirrhosis. Patients with cirrhosis are immunocompromised and increased susceptibility to develop spontaneous bacterial infections, hospital-acquired infections, and a variety of infections from uncommon pathogens. Once infection develops, the excessive response of pro-inflammatory cytokines on a pre-existing hemodynamic derangement in cirrhosis further predispose the development of serious complications such as shock, acute-on-chronic liver failure, renal failure, and death. The incidence of resistant bacteria has continually increased, especially in healthcare-associated settings. Preventive measures, early recognition and proper management are necessary to minimize morbidity and mortality of infections in cirrhosis.